Organisation paid for research Program year 2025 Source: CMS Open Payments

Retina Associates

Neither a doctor nor a teaching hospital

Research payments

$3,234,371

385 payments

Through program year 2025, Retina Associates is reported as receiving $3,234,371 in research payments, across 385 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $25,900 11
2024 Research $4,154 1
2023 Research $230,664 100
2022 Research $81,903 6
2021 Research $1,281,685 103
2020 Research $1,111,019 106
2019 Research $499,045 58

Breakdown

Who paid Research payments · program years 2019–2025
  1. Genentech, Inc. $2,669,056 257 payments
  2. Bayer HealthCare Pharmaceuticals Inc. $296,849 97 payments
  3. Novartis Pharmaceuticals Corporation $166,754 11 payments
  4. Amgen Inc. $75,662 8 payments
  5. Astellas Pharma Global Development $25,900 11 payments
  6. Allergan Inc. $150 1 payment
Studies the money was for Research payments · program years 2019–2025
  1. Study of the Port Delivery System With Ranibizumab in Patients With Diabetic MacUlar Edema $690,754 45 payments
  2. Va2 Phiii Yosemite $549,879 44 payments
  3. Port Delivery System for Ranibizumab $511,285 55 payments
  4. Va2 Phiii $256,733 32 payments
  5. Port Delivery System of Ranizibumab Extension Study $175,635 28 payments
  6. A Phase III Multicenter Observation Comparator Study of the Efficacy Safety and Pharmacokinetics $169,613 16 payments
  7. A 96-Week, Two-Arm, Randomized, Single-Masked, Multi-Center, Phase III Study Assessing the Efficacy and Safety of Brolucizumab 6 MG Compared to Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy $166,690 10 payments
  8. Faricimab Dme Long Term Extension Rhone X $148,154 19 payments
  9. BAY865321, HD 8mg, AMD - Ph 3 $120,941 40 payments
  10. BAY865321 HD 8mg AMD - Ph 3 $110,465 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record